Literature DB >> 14626691

The pathophysiology of motor symptoms in Parkinson's disease.

P Santens1, P Boon, D Van Roost, J Caemaert.   

Abstract

This review focuses on some of the known and hypothetical pathophysiological mechanisms underlying the motor symptoms in Parkinson's disease (PD). Current views on these mechanisms have largely been influenced by models of basal ganglia functioning and dysfunctioning. These models have allowed to explain some clinical findings and to predict a number of results of basal ganglia surgery in movement disorders. However, neurophysiological studies as well as neurochemical data have broadened our vision on basal ganglia functioning and dysfunctioning in PD. Moreover, these more fundamental insights in basal ganglia functioning allow new concepts on the development of treatment strategies, and on the prevention of motor fluctuations in PD.

Entities:  

Mesh:

Year:  2003        PMID: 14626691

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  13 in total

Review 1.  Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson's Disease: A Narrative Review.

Authors:  Jeremy M Morowitz; Kaylyn B Pogson; Daniel A Roque; Frank C Church
Journal:  Brain Sci       Date:  2022-04-22

2.  The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson's disease.

Authors:  Omar M E Abdel-Salam; Safaa M Youssef Morsy; Eman R Youness; Noha N Yassen; Amany A Sleem
Journal:  Iran J Basic Med Sci       Date:  2020-09       Impact factor: 2.699

Review 3.  Current and emerging therapeutic targets for Parkinson's disease.

Authors:  Tanvi Pingale; Girdhari Lal Gupta
Journal:  Metab Brain Dis       Date:  2020-10-22       Impact factor: 3.584

4.  Impact of Cognitive Loading on Postural Control in Parkinson's Disease With Freezing of Gait.

Authors:  Wannipat Buated; Praween Lolekha; Shohei Hidaka; Tsutomu Fujinami
Journal:  Gerontol Geriatr Med       Date:  2016-11-03

5.  Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's disease.

Authors:  Sora Ahn; Taek-Jin Song; Seong-Uk Park; Songhee Jeon; Jongpil Kim; Joo-Young Oh; Jaehwan Jang; Sanhwa Hong; Min-A Song; Hye-Seoung Shin; Young-Rim Jung; Hi-Joon Park
Journal:  BMC Complement Altern Med       Date:  2017-04-19       Impact factor: 3.659

Review 6.  Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.

Authors:  Panchanan Maiti; Jayeeta Manna; Gary L Dunbar
Journal:  Transl Neurodegener       Date:  2017-10-25       Impact factor: 8.014

7.  In Vitro, In Silico, and In Vivo Assessments of Pharmacokinetic Properties of ZM241385.

Authors:  Jin-Ju Byeon; Min-Ho Park; Seok-Ho Shin; Yuri Park; Byeong Ill Lee; Jang-Mi Choi; Nahye Kim; Seo-Jin Park; Min-Jae Park; Jeong-Hyeon Lim; Young-Guk Na; Young G Shin
Journal:  Molecules       Date:  2020-03-02       Impact factor: 4.411

8.  Effects of Combined Treatment with Acupuncture and Chunggan Formula in a Mouse Model of Parkinson's Disease.

Authors:  Tae-Yeon Hwang; Min-A Song; Sora Ahn; Ju-Young Oh; Dong-Hee Kim; Quan Feng Liu; Wonwoong Lee; Jongki Hong; Songhee Jeon; Hi-Joon Park
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-21       Impact factor: 2.629

9.  Quantitative electromyographic analysis of reaction time to external auditory stimuli in drug-naïve Parkinson's disease.

Authors:  Do-Young Kwon; Byung Kyu Park; Ji Won Kim; Gwang-Moon Eom; Junghwa Hong; Seong-Beom Koh; Kun-Woo Park
Journal:  Parkinsons Dis       Date:  2014-03-02

10.  Physiological and Functional Basis of Dopamine Receptors and Their Role in Neurogenesis: Possible Implication for Parkinson's disease.

Authors:  Akanksha Mishra; Sonu Singh; Shubha Shukla
Journal:  J Exp Neurosci       Date:  2018-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.